Azenta Past Earnings Performance

Past criteria checks 0/6

Azenta's earnings have been declining at an average annual rate of -32.3%, while the Life Sciences industry saw earnings growing at 19.7% annually. Revenues have been declining at an average rate of 0.2% per year.

Key information

-32.3%

Earnings growth rate

-36.5%

EPS growth rate

Life Sciences Industry Growth19.5%
Revenue growth rate-0.2%
Return on equity-6.8%
Net Margin-23.4%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Azenta makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BOVESPA:A2ZT34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24652-15230235
31 Dec 23641-1729735
30 Sep 23665-1331134
30 Jun 23630-2130233
31 Mar 23597-2628530
31 Dec 22594-2527929
30 Sep 22555-1124728
30 Jun 22555-2826726
31 Mar 22551-2326725
31 Dec 21535-2926124
30 Sep 21514-2925222
30 Jun 21114-69183-10
31 Mar 21205-53185-2
31 Dec 20296-371839
30 Sep 20389-2619018
30 Jun 208504123259
31 Mar 208342822459
31 Dec 198121621758
30 Sep 19334-6115717
30 Jun 19741319454
31 Mar 19710718251
31 Dec 186687217049
30 Sep 186326816347
30 Jun 184883515441
31 Mar 184984714940
31 Dec 17510-214640
30 Sep 175271114140
30 Jun 176695613646
31 Mar 176344713247
31 Dec 16600-5112749
30 Sep 16434-8511644
30 Jun 16549-7312352
31 Mar 16546-7411952
31 Dec 155501211752
30 Sep 155531411452
30 Jun 15529811253
31 Mar 15502-311254
31 Dec 14489-311154
30 Sep 14483111053
30 Jun 14471310751
31 Mar 144641010249
31 Dec 1344859748
30 Sep 13422-79746
30 Jun 134311079645

Quality Earnings: A2ZT34 is currently unprofitable.

Growing Profit Margin: A2ZT34 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A2ZT34 is unprofitable, and losses have increased over the past 5 years at a rate of 32.3% per year.

Accelerating Growth: Unable to compare A2ZT34's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A2ZT34 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-1.7%).


Return on Equity

High ROE: A2ZT34 has a negative Return on Equity (-6.85%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.